Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure

This study has been completed.
Information provided by:
University Hospital, Ghent Identifier:
First received: October 10, 2006
Last updated: April 24, 2009
Last verified: April 2009

A prospective randomized study to compare 2 groups:

  • heparine lock with positive pressure
  • lock without a needle with positive pressure

Condition Intervention
Device: Catheter locking systems

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Prospective Study Which Compares the Use of a Closing System Without a Needle and With Positive Pressure to a Heparin Lock With Positive Pressure for Patients With a Catheter for Chemotherapy

Resource links provided by NLM:

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Clinical evaluation

Estimated Enrollment: 60
Study Start Date: November 2006
Study Completion Date: July 2007
Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Oncological patients who require intravenous chemotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00386451

University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Principal Investigator: Caren Randon, MD University Hospital, Ghent
  More Information

Additional Information:
Responsible Party: Caren Randon, University Hospital Ghent Identifier: NCT00386451     History of Changes
Other Study ID Numbers: 2006/331 
Study First Received: October 10, 2006
Last Updated: April 24, 2009
Health Authority: Belgium: Institutional Review Board

Keywords provided by University Hospital, Ghent:
Intravenous chemotherapy

Additional relevant MeSH terms:
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action processed this record on October 28, 2016